Week 282 Review - Superb end to a traumatic year

I was really hoping we wouldn't have a down week at the end of 2020, although it would have probably summed up the year quite well. I needn't have worried, as the final week, despite being very short, was absolutely brilliant.

I went a bit mad too, and cashed in some profits to buy into new things, as well as taking more profits from the trading account.

Fortunately OPTI:Optibiotix Health had a rally over the last few days which accounted for much of this week's rise, but JLP:Jubilee Metals and SBTX:SkinBioTherapeutics also played a big part.

The result was a narrowing of the deficit between cost and value of £12,735, so that deficit now stands at a relatively small £7,729 and the overall portfolio value has hit another milestone, standing at £120,024. That's a very nice way to end the year as it's the highest ever portfolio value. Granted I've added another £30k since my previous record valuation so I have cheated slightly in achieving the record.

Worst performer was a new share ITX:Itaconix which I dipped a little toe in with some SIPP profits to buy 16,297 shares at 3.068p costing £511.94. I like to put a small marker down so I start to follow the story more closely. If I like what I see I may add, else I ditch them. These have a wide spread and dropped a little after I bought them, so they are 16% down already.

FXPO:Ferrexpo have been doing amazingly well recently, but this week they dropped 7%. I suspect a little profit taking and nerves over a blip in the iron ore price. I'm still hoping for a special dividend in January.

My only other big loser was DDDD:4D Pharma which I'm back in now. One of the holdings is my trading account, so the small amount and commission meant that ended the week 7% down on when I bought it. The larger new SIPP holding only dropped 4%.

IES:Invinity Energy has been on a bit of a roll as more contracts are announced. It climbed another 5% this week and is only 55% down now. There may yet be hope of salvaging something from the RED:RedT Energy mess.

OPTI:Optibiotix had a spurt in the last 2 days and climbed 8p which is 13% and accounts for £10k of this week's rise. Could 2021 be the year when this finally takes off?

TRX:Tissue Regenix has climbed a little, but it's showing a 20% improvement. That's because I decided that now the Woodford holding has been mostly sold off, and all the people that panicked have finished selling, this is looking like a reasonable recovery play. I was stuck with an average purchase price of 18p, so this was going to be showing a loss for a long time. I took fairly drastic action and bought 90,594 shares at 0.5464p costing £506.96. That brought my average price down from 18p to 2.26p. I think there's a much better chance of that getting into profit than if I'd kept just the 18p holding. Once Covid settles down and operations start happening again, demand for their products will be high, and although everything went wrong for Woodford, you could argue that his investors just got impatient.

JLP:Jubilee Metals would normally get Share of the Week for a 30% increase, as the meteoric rise continues. I'm expecting a trace back to 12p from today's 12.7p until next news, but I'm hanging onto these long term now as there's so much in the pipeline that it's too dangerous to trade. My holding is now 194% up and making £8,372 potential profit. Happy days.

Share of the Week is SBTX:SkinBioTherapeutics which climbed 40% from a 14% loss to a 26% profit. I treated them quite badly and sold all my trading shares and 30% of my SIPP shares for a small profit to fund my purchases mentioned above. I'm not very good at being disciplined with my SBTX trading, as the reason for it is meant to be so I can buy more on dips, but I keep spending all the proceeds. I still have 15,581 shares though, and they are currently making £696 potential profit.

A joy to behold. The nearest to break-even for over a year, and a stunning recovery from the Covid crash.

What a difference a week makes!

Here's the ISA and share portfolios after week 22 of year 6

			Weekly Change
Cash	£36.70		+£0
Portfolio cost	£63,009.29		+£0
Portfolio sell value (bid price-commission)	£57,952.97	(-8.0%)	+£7,206.02
Potential profits	£8,372.05		+£1,300.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£591.81		+£0
Yr 6 Average monthly cash profit	£112.88	(3.2%)	-£5.37
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,018.42		+£0
Average monthly cash profit	£339.75	(9.8%)	-£1.21
(Sold stocks profit + Dividends - Fees  / Months)
Compound performance	53%		+0%

Not much activity in this account compared to the others, but JLP:Jubilee Metals put on a 1.3p spurt worth £1,300 and most of the rest of the £7,206 improvement is OPTI:Optibiotix Health narrowing losses.

Still quite a deficit to make up on this one. I'm hoping that IQE:IQE will get to 100p as that will give me £700 profit, which will be enough to write off BLCC:Block Commodities from my portfolio without leaving a big hole in performance. I really want to write off these no-hope shares so I don't have to go through the admin of updating them or even looking at the horrible worthless things.

The gap to make up is just £5,000 and we'll cross the fabled £0 line.

The SIPP looks like this after week 266 overall and week 6 of year 6

			Weekly Change
Cash	£286.44		-£182.45
Portfolio cost	£61,813.33		+£854.42
Portfolio sell value (bid price - commission)	£59,531.72	(-3.7%)	+£5,414.03
Potential profits	£5,579.08		+£595.53
Yr 6 Dividends	£360.50		+£13.88
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£370.59		+£370.59
Yr 6 Average monthly cash profit	£515.97	(15.4%)	+£230.00
Total Dividends	£2,427.58		+£13.88
Total Interest	£0.20		+£0
Total Profit from sales	£15,830.03		+£370.59
Average monthly cash profit	£287.05	(8.6%)	+£5.21
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	44%		+1%

OK - there's a lot going on here so I'll document events chronologically.

First I decided I wanted to buy something with my CAML:Central Asia Metals dividend, but it wasn't quite enough so I added £150. I wanted more gold, and have been watching HUM:Hummingbird Resources for years. They are high risk because of the territory where they operate in Mali and Liberia, but they have been there for over 10 years and are climbing back towards the 40p they were trading at during the summer. I bought 1,538 shares at 32.5p costing £511.50 and I think of them as mostly free as they came (nearly) from the CAML dividend. I doubt I'll hold them long, and will probably re-invest in CAML after selling.

I've discussed the next event near the top of the blog when I massively increased my TRX:Tissue Regenix holding. I got the cash for that by selling 216 CAML:Central Asia Metals shares to liberate £517.59 and make £121.63 (29.8%) profit. It was a bit naughty as I don't want to reduce CAML, but I saw an opportunity to salvage something from my TRX investment and took it.

Next was my naughty top-slice of SBTX:SkinBioTherapeutics. I sold 7,500 shares at 20.705p after paying 17.22p and made £248.96 (19%) profit. This liberated £1,540 which I needed to get back into DDDD:4D Pharma before their Nasdaq listing and the small toe-dip in ITX:Itaconix I described near the start of the blog. 

I bought 769 shares in DDDD:4D Pharma at 130p costing £1,011.65. They did drop back a few pence so I'm down 4% but wanted to be in for the January ride as it could get thrilling and I desperately wanted to keep a long-term holding in this one after my opportunistic profit-taking a few months ago when I made a nice £2,258 profit. This time I want to hold them for the whole adventure.

The the re-investing of dividend, injection and profits caused the cost to go up by £845, but cash went down less thanks to £137.50 tax rebate in my AJ Bell SIPP account. Profits increased by £595 despite the sells and overall value got a big boost from OPTI:Optibiotix Health. Annual performance looks flattering, but it's projected based on the first 6 weeks so won't last, and long term performance ticked up by 0.1% to 8.6%.

We're so, so close to that cost line now.

About £2,200 to make up. Another week like this, or even half as good as this will do the trick.

The trading account looks like this after week 232 overall and week 24 of year 5

			Weekly Change
Cash	£240.85		-£1.05
Portfolio cost	£2,367.41		-£0.14
Portfolio sell value (bid price - commission)	£1,975.59	(-16.6%)	+£115.33
Potential profits	£0		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£565.91		+£98.81
Yr 5 Average monthly cash profit	£104.38	(52.9%)	+£14.08
Dividends	£60.10		+£0
Profit from sales	£852.28		+£98.81
Average monthly cash profit	£17.04	(8.6%)	+£1.78
(Sold stocks profit + Dividends - Fees  / Months)

I sold my SBTX:SkinBioTherapeutics shares at 20.55p making £98.91 (18.8%) profit and liberated another £100 back to my bank account. I'm now trading with a purpose as I'm planning a trip to Madagascar next year and this can contribute to my holiday fund. The sooner my share account OPTI:Optibiotix holding gets into profit the sooner I can transfer that into this pot. as my plan is to at least double up the amount available so there's more chance I can trade something every week.

I re-invested the £500 in DDDD:4D Pharma, buying 383 shares at 130.5p, which are 7% down. However, CAML:Central Asia Metals is only 5% down and OPTI:Optibiotix is only 1% down, so it's possible I will have 3 active pots. I may even use one profit to write off my IQE:IQE loss as it will take them ages to break even and I could be using the pot for something else.

The dip from a few weeks ago is fixed, and the orange line continues to drop. I don't expect this account to ever have the chance to cross the red line.

That will do nicely. an increase despite cashing in £98 profit is great.

Here's my wish list:

1. JLP:Jubilee Metals to announce permission to process platinum rich tailings at DCM and the fine chrome plant move is completed and operation. Nope, but I'm getting beyond caring.
   
2. OPTI:Optibiotix Health to get within 10% of profit. Yes! This one can now be upgraded to getting back into profit.
3. CMCL:Caledonia Mining reverses the down trend and gets back into profit. Down again this week. I'm really surprised. Good job this is a long term holding, but it's letting down my magic formula shares badly.
   
4.  SBTX:SkinBioTherapeutics gets back into profit. Yes! I can't think of any more wishes for this one yet. I need to work out how to get my 7,500 shares back that I sold. This wish is now retired as complete.
5. The combined portfolios get back into the black. This one is getting close now - will it come true next week or will there be a post-Brexit slump?

2020 has been a very trying year, but the portfolio is in a much better place at the end than it was at the beginning, despite the terrifying crash in March. The big winner in 2020 has been the magic formula trial, with all but one of the shares in profit, and over £2,000 potential profit based on £6,000 investment, and over £200 in dividends. I'm happy this is a great way to pick shares and look forward to February or March when I get my next £2,000 pension transfer to pick another 2, and really looking forward to June when I can start selling the ones I bought last year and realising the profits.

Here's to 2021 where some of my shares could get a chance to really shine.